Burning Rock Biotech Ltd
Diagnostics & Research
Healthcare
BNR
1.08 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.00
52 week high
10.17
high
9.50
52 week low
0.00
low
8.96
growth
184.21 %
previous Close
9.02
P/E ratio
market cap
102 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
27.73 %
eps surprise
0.00 %
net profit margin
0.00 %
64.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top